Anzeige
Erschienen in:
05.05.2016 | Original Research
Transcatheter aortic valve replacement in patients with prior chest irradiation and severe aortic stenosis
Erschienen in: Journal of Radiation Oncology | Ausgabe 3/2016
Einloggen, um Zugang zu erhaltenAbstract
Background/methods
Transcatheter aortic valve replacement (TAVR) in patients with severe aortic stenosis, prior chest irradiation, and porcelain aorta may be preferable to traditional surgery but has not been previously evaluated.
Results
Ten patients (mean age 60 years, 50 % male) with severe aortic stenosis (valve area 0.68 ± 0.15 cm2), prior chest irradiation for malignancy, and porcelain aorta underwent TAVR (transfemoral in 90 %). The procedure was successful in all patients with average ICU stay of 1.2 ± 0.6 days, overall hospital stay of 4.8 ± 1.8 days, and 30-day mortality of 0 %.
Conclusions
TAVR is a safe and effective alternative treatment in aortic stenosis patients with prior chest irradiation and porcelain aorta and may very well become the preferred approach.